Deerfield Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,890,000
Closed -$4.9M 160
2025
Q2
$4.9M Hold
1,890,000
0.09% 75
2025
Q1
$12.7M Buy
1,890,000
+355,237
+23% +$2.52M 0.25% 62
2024
Q4
$10.4M Buy
+1,534,763
New +$10.1M 0.2% 64
2024
Q3
Sell
-47,539
Closed -$301K 569
2024
Q2
$301K Buy
47,539
+27,250
+134% +$210K 0.01% 341
2024
Q1
$188K Buy
+20,289
New +$238K ﹤0.01% 339
2023
Q4
Sell
-1,017,958
Closed -$10.5M 229
2023
Q3
$10.5M Sell
1,017,958
-46,327
-4% -$537K 0.23% 56
2023
Q2
$14M Sell
1,064,285
-1,338,419
-56% -$16.4M 0.3% 58
2023
Q1
$26.9M Buy
+2,402,704
New +$23.7M 0.6% 43
2022
Q4
Sell
-3,720,901
Closed -$62M 113
2022
Q3
$62M Buy
3,720,901
+255,000
+7% +$4.7M 1.23% 27
2022
Q2
$51M Sell
3,465,901
-229,440
-6% -$4.73M 1.05% 32
2022
Q1
$91.7M Buy
3,695,341
+1,328,474
+56% +$34.3M 2.05% 14
2021
Q4
$75.9M Buy
2,366,867
+336,980
+17% +$12.3M 1.59% 19
2021
Q3
$73M Buy
2,029,887
+229,000
+13% +$9.01M 1.43% 19
2021
Q2
$79.5M Buy
1,800,887
+863,855
+92% +$37.6M 1.41% 14
2021
Q1
$42.9M Buy
937,032
+473,521
+102% +$27.2M 0.9% 36
2020
Q4
$32M Buy
+463,511
New +$22.7M 0.63% 47

Other funds holding LUNG

Deerfield Management's LUNG Position: Q3 2025 in Review

Deerfield Management sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 1,890,000 shares — an estimated $4.9M sold.

Deerfield Management first reported a position in LUNG in Q4 2020 and held it in 16 quarters. The position peaked at $91.7M in Q1 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

  • Deerfield Management reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 1,890,000 Pulmonx shares in Q3 2025, an estimated $4.9M.
  • Deerfield Management first reported a position in Pulmonx in Q4 2020 and held it in 16 quarters.
  • Deerfield Management's Pulmonx position peaked at $91.7M in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.